Industry Perspective and Career Opportunities
The biopharmaceutical industry continues to grow, with constant new advances that are generating opportunities for scientific exploration and employment. New biotechnology-derived pharmaceutical products are gaining approval on a worldwide basis, the sequencing of the human genome is leading to tremendous new insights into the molecular understanding of many diseases with the hope for treatments or cures. The challenges are many and we require dedicated scientists and engineers educated in bioprocessing with knowledge and practical training in biologics. Students who complete the KGI two-year MEng course program will emerge with the technical knowledge, skills, insights and real world experience needed for success in the biopharmaceutical industry.
Dr. Robert Baffi, Executive Vice President Technical Operations, BioMarin Pharmaceutical Inc., & Chair, Amgen Bioprocessing Center Advisory Committee (ABCAB), Keck Graduate Institute
High quality workforce skilled in biopharmaceutical process design, development and manufacturing is important to the Future of Boehringer Ingelheim. KGI's Program provides an excellent and flexible platform for recruitment of the next generation of bioprocess engineers that can meet the demand of the biopharmaceutical industry and for closing the gap between academic and industry. I have hired several students from KGI. They do well at BI. They arrive knowing the fundamentals of drug development in biotechnology and bioprocessing. We consistently recruit students from KGI in many departments including Process Development, QA, QC, Manufacturing and Manufacturing Sciences.
Dr. Jon Coffman, Director of Bioprocess Engineering, Boehringer Ingelheim
The Master of Engineering (MEng) in Biopharmaceutical Processing program at KGI will train students in a critical cross disciplinary program that is key in translating biopharmaceutical discoveries into clinical and commercial successes. It draws from a wide range of fields including medicine, chemistry, biology, molecular biology, business and chemical engineering to create a unique program that trains the future workforce for the biopharmaceutical industry. The faculty and guest lecturers list features several leading bioprocess leaders from across industry and academia that is certain to impart students with a unique advantage in today's highly competitive biopharmaceutical sector.
Dr. Abhinav Shukla, Vice President, Process Development and Manufacturing, KBI Biopharma